BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination.
Clinical trial NCT03867942 · UNKNOWN
Trial details
- NCT number
- NCT03867942
- Sponsor
- LG Chem
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-21
- Primary completion
- 2019-05-24
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.